Parkin介导的线粒体自噬及细胞器互作机制

线粒体是细胞生理代谢活动发生的重要场所.线粒体生发降解平衡是维持能量代谢稳定的重要保障.Parkin作为E3泛素连接酶,通过PINK1/Parkin、LC3等多种信号参与调控线粒体自噬过程.此外,Parkin还能够影响线粒体相关内质网膜、调控细胞器间钙流,在线粒体-内质网对话过程中调控溶酶体途径介导的线粒体自噬.脂肪组...     

PINK1/Parkin介导的线粒体自噬

线粒体自噬（mitochondrial autophagy, or mitophagy）指的是细胞通过自吞噬作用,降解与清除受损线粒体或者多余线粒体,其对整个线粒体网络的功能完整性和细胞存活具有重要作用。线粒体自噬过程受多种途径调控,PINK1/Parkin通路是其中的一条,其异常与多种疾病的发生密切相关,如心血管疾病、肿瘤和帕金森病等。在去极化线粒体中,磷酸酶及张力蛋白同源物(PTEN)诱导的激酶1（PTEN-induced kinase 1,PINK1）作为受损线粒体的分子传感器,触发线粒体自噬的起始信号,并将Parkin募集至线粒体;Parkin作为线粒体自噬信号的“增强子”,通过对线粒体蛋白质进一步泛素化介导自噬信号的扩大;去泛素化酶和PTEN-long蛋白参与调控该过程,并对维持线粒体稳态具有重要作用。本文主要对PINK1与Parkin蛋白质的分子结构和其介导线粒体自噬发生的分子机制,以及参与调控该途径的关键蛋白质进行综述,为进一步研究以线粒体自噬缺陷为特征的疾病治疗提供理论基础。     

综述: 细胞自噬的研究方法

细胞自噬的研究是目前生物医学领域热点之一,广泛参与各种生理和病理过程．目前普遍采用的自噬检测方法包括电镜、免疫荧光、蛋白质印迹等方法检测自噬体及其标志蛋白．研究的深入对自噬的检测方法也提出了更高的要求,自噬功能障碍包括自噬体形成和降解障碍,因此,准确全面地评估自噬不仅包括自噬体的检测,还包括动态观察整个自噬性降解的过程是否顺畅(即自噬潮分析)．另外,通过药物或基因干预技术来人为地调控自噬以观察其在体内体外模型中的作用也是自噬分析的重要内容．需要注意的是,任何一种方法单独应用均不能作为自噬的依据,对任何方法得到的结果进行解释时必须慎重,特别是不能将自噬体的增多减少或自噬相关蛋白表达的高低等同于自噬的增强或减弱．     

细胞自噬及真菌中自噬研究概述

细胞自噬是真核生物中广泛存在的、主要依赖于溶酶体或液泡的保守的降解途径,通过降解细胞内过多或异常的蛋白、细胞器等以维持正常的细胞功能。近10年来自噬研究方面的飞速进展显示出自噬与癌症、神经退行性疾病、衰老及心脏病等人类疾病相关。与此同时,自噬在丝状真菌的生长、形态和发育等方面发挥着重要作用,特别是在丝状真菌的细胞分化过程中,自噬起到了关键性作用,如致病性生长、程序性细胞死亡及孢子形成。本文主要论述了什么是自噬,自噬的检测方法及以真菌为对象的自噬研究进展。     

细胞自噬研究进展

细胞自噬是真核生物在进化过程中高度保守、基于溶酶体的一种胞内降解途径,对维持细胞和生物体的稳态平衡有重要作用。研究表明,自噬参与生物体发育、免疫反应、代谢调节、细胞凋亡和衰老等多种过程。自噬功能异常与神经退行性疾病、肿瘤等的发生发展密切相关。近30年,我们对细胞自噬的认识无论是在分子机制上还是生理功能方面都有了长足的发展。为进一步加深对细胞自噬的认识,该文主要对细胞自噬的概念、自噬核心机器的组成及调控机制、自噬类型、生理功能及与疾病的关系作一简单综述。     

细胞自噬与病毒感染

自噬是广泛存在于真核细胞内的一种溶酶体依赖性降解途径,在维持细胞存活、更新、物质再利用和内环境稳定中起着重要作用。目前已经发现大量新的自噬相关基因,同时发现自噬在病毒感染过程中发挥着重要的抗病毒作用:自噬可以将胞质中的病毒转运到溶酶体中,降解病毒;也可以将病毒核酸转运至胞内感受器上激活天然免疫;还可以将病毒抗原递呈给MHCⅡ类分子激活适应性免疫。自噬参与胞内微生物感染具有双重作用。一方面,自噬能够降解入侵的微生物,即以异源吞噬(xenophagy)的方式清除胞内的病原体;另一方面,有些微生物能够通过某些机制逃避自噬而利于自身存活。本文就细胞自噬及其与不同病毒感染关系的最新研究进展进行综述。     

Pink1/Parkin信号通路调控线粒体自噬的研究进展

线粒体自噬是指为了维持细胞内环境稳定而通过选择性自噬来降解功能失调或过剩的线粒体。在众多线粒体自噬相关通路研究中,对Pink1/Parkin信号通路的探索较为详细。在哺乳动物细胞中,Ser/Thr蛋白激酶Pink1和E3泛素连接酶Parkin协同作用,感知线粒体功能状态并对受损的线粒体进行标记,以促进其通过自噬途径进行降解。同时,泛素化和去泛素化在调节Parkin和线粒体自噬活性中起着重要的作用。本文就Pink1/Parkin信号通路以及去泛素化酶在线粒体自噬中的作用进行综述。     

受体相互作用蛋白3（RIP3）调控细胞自噬的研究进展

受体相互作用蛋白3(receptor-interacting protein 3,RIP3)是一种丝氨酸-苏氨酸蛋白激酶，因其参与细胞自噬的调控而受到广泛关注。本文就RIP3在细胞自噬的发展和调控机制中的作用进行了总结。RIP3可参与mTOR信号通路的调节，同时与多种自噬所必须的蛋白发生相互作用，包括GNAI3/RGSI9、P62和TFEB等，从而其在自噬启动、自噬体形成和自噬溶酶体成熟等多个阶段发挥正向或负向调控作用，为进一步探究RIP3对细胞程序性死亡的调控机制及相关疾病治疗的潜在分子靶标筛选提供参考。     

番鸭呼肠孤病毒感染诱导细胞自噬的研究

本研究通过透射电镜观察自噬体的形态学结构,蛋白免疫印迹(Western blot)检测细胞自噬相关蛋白LC3II和磷酸化mTOR(p-mTOR)表达量的动态变化趋势,探索番鸭呼肠孤病毒(MDRV)感染对细胞自噬的影响。结果显示,MDRV-YB株感染的DF-1细胞中可见典型的包裹胞浆成分的双层膜结构;MDRV感染番鸭成纤维细胞(MDFs)和DF-1细胞后0~60h内,其LC3II表达量均呈现先升高后降低的趋势,且均在感染后36h达到最大值,其p-mTOR表达量均呈现先降低后回升的趋势,且分别在感染后36h和24h达到最低值;灭活MDRV组细胞未见LC3II表达。结果表明MDRV能够诱导感染的MDFs和DF-1细胞持续较长时间细胞自噬,而灭活的MDRV不能引起细胞自噬。     

细胞自噬与肿瘤耐药

细胞自噬是一种细胞自我降解的过程,在适应代谢应激、保持基因组完整性及维持内环境稳定方面发挥重要作用. 在肿瘤治疗中,凋亡耐受是产生肿瘤耐药的重要机制. 细胞自噬可防止抗肿瘤药诱导的凋亡,促进肿瘤耐药. 然而,自噬性细胞死亡可能是凋亡耐受肿瘤细胞的一种死亡方式. 因此,细胞自噬对肿瘤细胞的耐药性有双重影响. 本文综述了细胞自噬的分子机制、细胞自噬与凋亡的关系、细胞自噬与肿瘤耐药以及治疗的主要研究进展.     

Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation

Loss-of-function mutations in the parkin gene (PARK2) and PINK1 gene (PARK6) are associated with autosomal recessive parkinsonism. PINK1 deficiency was recently linked to mitochondrial pathology in human cells and Drosophila melanogaster, which can be rescued by parkin, suggesting that both genes play a role in maintaining mitochondrial integrity. Here we demonstrate that an acute down-regulation of parkin in human SH-SY5Y cells severely affects mitochondrial morphology and function, a phenotype comparable with that induced by PINK1 deficiency. Alterations in both mitochondrial morphology and ATP production caused by either parkin or PINK1 loss of function could be rescued by the mitochondrial fusion proteins Mfn2 and OPA1 or by a dominant negative mutant of the fission protein Drp1. Both parkin and PINK1 were able to suppress mitochondrial fragmentation induced by Drp1. Moreover, in Drp1-deficient cells the parkin/PINK1 knockdown phenotype did not occur, indicating that mitochondrial alterations observed in parkin- or PINK1-deficient cells are associated with an increase in mitochondrial fission. Notably, mitochondrial fragmentation is an early phenomenon upon PINK1/parkin silencing that also occurs in primary mouse neurons and Drosophila S2 cells. We propose that the discrepant findings in adult flies can be explained by the time of phenotype analysis and suggest that in mammals different strategies may have evolved to cope with dysfunctional mitochondria.Many lines of evidence suggest that mitochondrial dysfunction plays a central role in the pathogenesis of Parkinson disease, starting from the early observation that the complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced acute and irreversible parkinsonism in young drug addicts (for review, see Refs. 1–3). In support of a crucial role of mitochondria in Parkinson disease, several Parkinson disease-associated gene products directly or indirectly impinge on mitochondrial integrity (for review, see Refs. 4–6). A clear link between Parkinson disease genes and mitochondria has recently emerged from studies on PINK1 (PTEN-induced putative kinase 1), a mitochondrial serine/threonine kinase, and parkin, a cytosolic E3 ubiquitin ligase. Drosophila parkin null mutants displayed reduced life span, male sterility, and locomotor defects due to apoptotic flight muscle degeneration (7). The earliest manifestation of muscle degeneration and defective spermatogenesis was mitochondrial pathology, exemplified by swollen mitochondria and disintegrated cristae. Remarkably, Drosophila PINK1 null mutants shared marked phenotypic similarities with parkin mutants, and parkin could compensate for the PINK1 loss-of-function phenotype but not vice versa, leading to the conclusion that PINK1 and parkin function in a common genetic pathway with parkin acting downstream of PINK1 (8–10). We recently demonstrated that PINK1 deficiency in cultured human cells causes alterations in mitochondrial morphology, which can be rescued by wild type parkin but not by pathogenic parkin mutants (11). We now present evidence that parkin plays an essential role in maintaining mitochondrial integrity. RNAi³-mediated knockdown of parkin increases mitochondrial fragmentation and decreases cellular ATP production. Notably, mitochondrial fragmentation induced by PINK1/parkin deficiency is observed not only in human neuroblastoma cells but also in primary mouse neurons and insect S2 cells. Alterations in mitochondrial morphology are early manifestations of parkin/PINK1 silencing that are not caused by an increase in apoptosis. The mitochondrial phenotype observed in parkin- or PINK1-deficient cells can morphologically and functionally be rescued by the increased expression of a dominant negative mutant of the fission-promoting protein Drp1. Moreover, manifestation of the PINK1/parkin knockdown phenotype is dependent on Drp1 expression, indicating that an acute loss of parkin or PINK1 function increases mitochondrial fission.     

Autophagy Enhances Intestinal Epithelial Tight Junction Barrier Function by Targeting Claudin-2 Protein Degradation

Autophagy is an intracellular degradation pathway and is considered to be an essential cell survival mechanism. Defects in autophagy are implicated in many pathological processes, including inflammatory bowel disease. Among the innate defense mechanisms of intestinal mucosa, a defective tight junction (TJ) barrier has been postulated as a key pathogenic factor in the causation and progression of inflammatory bowel disease by allowing increased antigenic permeation. The cross-talk between autophagy and the TJ barrier has not yet been described. In this study, we present the novel finding that autophagy enhances TJ barrier function in Caco-2 intestinal epithelial cells. Nutrient starvation-induced autophagy significantly increased transepithelial electrical resistance and reduced the ratio of sodium/chloride paracellular permeability. Nutrient starvation reduced the paracellular permeability of small-sized urea but not larger molecules. The role of autophagy in the modulation of paracellular permeability was confirmed by pharmacological induction as well as pharmacological and genetic inhibition of autophagy. Consistent with the autophagy-induced reduction in paracellular permeability, a marked decrease in the level of the cation-selective, pore-forming TJ protein claudin-2 was observed after cell starvation. Starvation reduced the membrane presence of claudin-2 and increased its cytoplasmic, lysosomal localization. Therefore, our data show that autophagy selectively reduces epithelial TJ permeability of ions and small molecules by lysosomal degradation of the TJ protein claudin-2.     

Autophagy Inhibitor LRPPRC Suppresses Mitophagy through Interaction with Mitophagy Initiator Parkin

Autophagy plays an important role in tumorigenesis. Mitochondrion-associated protein LRPPRC interacts with MAP1S that interacts with LC3 and bridges autophagy components with microtubules and mitochondria to affect autophagy flux. Dysfunction of LRPPRC and MAP1S is associated with poor survival of ovarian cancer patients. Furthermore, elevated levels of LRPPRC predict shorter overall survival in patients with prostate adenocarcinomas or gastric cancer. To understand the role of LRPPRC in tumor development, previously we reported that LRPPRC forms a ternary complex with Beclin 1 and Bcl-2 to inhibit autophagy. Here we further show that LRPPRC maintains the stability of Parkin that mono-ubiquitinates Bcl-2 to increase Bcl-2 stability to inhibit autophagy. Under mitophagy stress, Parkin translocates to mitochondria to cause rupture of outer mitochondrial membrane and bind with exposed LRPPRC. Consequently, LRPPRC and Parkin help mitochondria being engulfed in autophagosomes to be degraded. In cells under long-term mitophagy stress, both LRPPRC and Parkin become depleted coincident with disappearance of mitochondria and final autophagy inactivation due to depletion of ATG5-ATG12 conjugates. LRPPRC functions as a checkpoint protein that prevents mitochondria from autophagy degradation and impact tumorigenesis.     

脂多糖通过自噬作用促进氧化低密度脂蛋白诱导的泡沫细胞的形成

目的:研究脂多糖(LPS)促进氧化低密度脂蛋白(ox-LDL)诱导的泡沫细胞形成的机制。方法:人源性THP-1细胞的培养,经ox-LDL诱导形成泡沫细胞。采用油红O染色鉴定泡沫细胞的形成,免疫荧光和Western blot方法检测自噬活性,观察自噬作用对泡沫细胞脂质沉积的影响。结果:①经形态学观察,脂多糖可以促进ox-LDL诱导的泡沫细胞的形成。②脂多糖可以激活自噬作用,并且自噬活性在16h达到最强。③脂多糖可以增强自噬激活剂雷帕霉素(Rap)的促自噬作用(P0.05),并且削弱自噬抑制剂3-甲基腺嘌呤(3-MA)的作用。④Rap单独作用不能影响泡沫细胞中脂质的累积,然而脂多糖能够增强Rap的作用,显著促进脂滴在泡沫细胞中的累积(P0.05);3-MA可以抑制基础水平和脂多糖诱导后泡沫细胞中脂滴的积累。结论:脂多糖通过增强自噬作用促进泡沫细胞的形成。     

Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung Infection

Pseudomonas aeruginosa is an opportunistic bacterial pathogen which is the leading cause of morbidity and mortality among cystic fibrosis patients. Although P. aeruginosa is primarily considered an extacellular pathogen, recent reports have demonstrated that throughout the course of infection the bacterium acquires the ability to enter and reside within host cells. Normally intracellular pathogens are cleared through a process called autophagy which sequesters and degrades portions of the cytosol, including invading bacteria. However the role of autophagy in host defense against P. aeruginosa in vivo remains unknown. Understanding the role of autophagy during P. aeruginosa infection is of particular importance as mutations leading to cystic fibrosis have recently been shown to cause a blockade in the autophagy pathway, which could increase susceptibility to infection. Here we demonstrate that P. aeruginosa induces autophagy in mast cells, which have been recognized as sentinels in the host defense against bacterial infection. We further demonstrate that inhibition of autophagy through pharmacological means or protein knockdown inhibits clearance of intracellular P. aeruginosa in vitro, while pharmacologic induction of autophagy significantly increased bacterial clearance. Finally we find that pharmacological manipulation of autophagy in vivo effectively regulates bacterial clearance of P. aeruginosa from the lung. Together our results demonstrate that autophagy is required for an effective immune response against P. aeruginosa infection in vivo, and suggest that pharmacological interventions targeting the autophagy pathway could have considerable therapeutic potential in the treatment of P. aeruginosa lung infection.     

Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells

Choline kinase-α (Chk-α) and autophagy have gained much attention, as they relate to the drug-resistance of breast cancer. Here, we explored the potential connection between Chk-α and autophagy in the mechanisms driving to tamoxifen (TAM) resistance, in estrogen receptor positive (ER+) breast cancer cells (BCCs). Human BCC lines (MCF-7 and TAM-resistant MCF-7 (MCF-7/TAM) cells) were used. Chk-α expression and activity was suppressed by the transduction of shRNA (shChk-α) with lentivirus and treatment with CK37, a Chk-α inhibitor. MCF-7/TAM cells had higher Chk-α expression and phosphocholine levels than MCF-7 cells. A specific downregulation of Chk-α by the transduction of shChk-α exhibited a significant decrease in phosphocholine levels in MCF-7 and MCF-7/TAM cells. The autophagy-related protein, cleaved microtubule-associated protein light chain 3 (LC3) and autophagosome-like structures were significantly increased in shChk-α-transduced or CK37-treated MCF-7 and MCF-7/TAM cells. The downregulation of Chk-α attenuated the phosphorylation of AKT, ERK1/2, and mTOR in both MCF-7 and MCF-7/TAM cells. In MCF-7 cells, the downregulation of Chk-α resulted in an induction of autophagy, a decreased proliferation ability and an activation of caspase-3. In MCF-7/TAM cells, despite a significant decrease in proliferation ability and an increase in the percentage of cells in the G0/G1 phase of the cell cycle, the downregulation of Chk-α did not induced caspase-dependent cell death and further enhanced autophagy and G0/G1 phase arrest. An autophagy inhibitor, methyladenine (3-MA) induced death and attenuated the level of elevated LC3 in MCF-7/TAM cells. Elucidating the interplay between choline metabolism and autophagy will provide unique opportunities to identify new therapeutic targets and develop novel treatment strategies that preferentially target TAM-resistance.     

Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma

The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway promotes melanoma tumor growth and survival while suppressing autophagy, a catabolic process through which cells collect and recycle cellular components to sustain energy homeostasis in starvation. Conversely, inhibitors of the PI3K/AKT/mTOR pathway, in particular the mTOR inhibitor temsirolimus (CCI-779), induce autophagy, which can promote tumor survival and thus, these agents potentially limit their own efficacy. We hypothesized that inhibition of autophagy in combination with mTOR inhibition would block this tumor survival mechanism and hence improve the cytotoxicity of mTOR inhibitors in melanoma. Here we found that melanoma cell lines of multiple genotypes exhibit high basal levels of autophagy. Knockdown of expression of the essential autophagy gene product ATG7 resulted in cell death, indicating that survival of melanoma cells is autophagy-dependent. We also found that the lysosomotropic agent and autophagy inhibitor hydroxychloroquine (HCQ) synergizes with CCI-779 and led to melanoma cell death via apoptosis. Combination treatment with CCI-779 and HCQ suppressed melanoma growth and induced cell death both in 3-dimensional (3D) spheroid cultures and in tumor xenografts. These data suggest that coordinate inhibition of the mTOR and autophagy pathways promotes apoptosis and could be a new therapeutic paradigm for the treatment of melanoma.     

Voltage-dependent Anion Channels (VDACs) Recruit Parkin to Defective Mitochondria to Promote Mitochondrial Autophagy

Mutations in the ubiquitin ligase Parkin and the serine/threonine kinase PINK1 can cause Parkinson disease. Both proteins function in the elimination of defective mitochondria by autophagy. In this process, activation of PINK1 mediates translocation of Parkin from the cytosol to mitochondria by an unknown mechanism. To better understand how Parkin is targeted to defective mitochondria, we purified affinity-tagged Parkin from mitochondria and identified Parkin-associated proteins by mass spectrometry. The three most abundant interacting proteins were the voltage-dependent anion channels 1, 2, and 3 (VDACs 1, 2, and 3), pore-forming proteins in the outer mitochondrial membrane. We demonstrate that Parkin specifically interacts with VDACs when the function of mitochondria is disrupted by treating cells with the proton uncoupler carbonyl cyanide p-chlorophenylhydrazone. In the absence of all three VDACs, the recruitment of Parkin to defective mitochondria and subsequent mitophagy are impaired. Each VDAC is sufficient to support Parkin recruitment and mitophagy, suggesting that VDACs can function redundantly. We hypothesize that VDACs serve as mitochondrial docking sites to recruit Parkin from the cytosol to defective mitochondria.